âTV May Be Bad for Your Brainâ
The New York Times Mind blog covers a recent study that suggests that watching three-hours of TV every day is associated with diminished cognitive...
How the News Frames the Opioid Epidemic
US news coverage has primarily framed the opioid drug abuse epidemic as a criminal justice issue rather than a public health problem, according to new research published ahead of print in the Journal of Psychiatric Services. The mediaâs framing of the epidemic may increase stigma against those who develop a dependency on prescription drugs and distract political attention from public-health oriented solutions, such as increased access to substance abuse recovery treatments.
FDA: New Depression Drug âNot Approvableâ
Gepirone, a new depression drug by Fabre-Kramer Pharmaceuticals, did not meet the FDAs efficacy standards. The new drug application for gepirone has now received...
The Ghost of Research Future
Two facts about Robert Califf are beyond question. He is an expert on clinical trials, who is already seen as a leading architect of the future of medical research. And as the New York Times put it, he has âdeeper ties to the pharmaceutical industry than any FDA commissioner in recent memoryâ. A lot of senior figures in medicine support Califf in spite of his ties to Pharma. The guy is just so bright, and understands the nuts and bolts of drug research so well! Surely a person like this is more useful than some outsider who offers only a squeaky-clean resume, they argue.
After the Black-Box: Majority of Children Starting SSRIs Still Receiving Too High of Dose
In 2004, the FDA added a black-box warning to SSRI antidepressants on the increased risk of suicide among children taking these drugs. A new study suggests that this warning has increased the proportion of children who begin an antidepressant on a low dose, but the majority are still receiving higher than recommended doses.
âSecond Patient Dies in Zafgen Obesity Drug Trialâ
Two patients have now died while taking the drug beloranib in an obesity drug trial. Both patients were in the active arm of the study and had received the drug rather than a placebo. Zafgen did not say whether it believed the drug had caused the blood clotting in the lungs that led to the patientâs death.
âMany in US Congress Hold Health Industry Investmentsâ
âAbout 30 percent of senators and 20 percent of representatives held assets in biomedical and health-care companies, or in specialty funds set up to invest...
Poor Evidence and Substantial Bias in Ritalin Studies
The authors of a large scale well-conducted systematic review of methylphenidate, also known as Ritalin, conclude that there is a lack of quality evidence for the drugâs effectiveness. Their research also revealed that Ritalin can cause sleep problems and decreased appetite in children.
Video: Bruce Levine on “The Anti-Authoritarian Movement to Rehumanize Mental Health”
Films for Action is now hosting a video by MIA contributor Bruce Levine. In his presentation, taped at his Oct 9, 2015 National Empowerment Center talk,...
Light Therapy Outperforms Prozac for Depression
In a new study, researchers found that bright light therapy was an effective treatment for nonseasonal major depressive disorder (MDD) while Prozac (Fluoxetine) alone...
âFDA Nominee Robert Califf Must Prove Independence from Industryâ
For STAT, Ed Silverman reports on growing concerns about the industry ties of the new nominee for FDA commissioner. Â âThe nomination comes at a...
âSuicide, Mental Illness Risks Increase During Recessionsâ
The latest economic recession led to a spike in diagnoses for mental illnesses, suicide attempts, and suicide, according to report out of the University...
Tailoring Teaching for Temperament Improves Engagement
"A classroom program that helps teachers adapt their interactions with students based on individuals' temperaments may lead to more student engagement in kindergarten, more...
âPunish People, Not Just Corporationsâ
Drug makers have faced large fines for unethical and harmful practices but have simply treated these as a cost of doing business. Ed Silverman reports...
âNew Pill for Boosting Female Libidos Off to a Slow Startâ
Ed Silverman reports that only 80 prescriptions for Addyi, or Flibanserin, were filled in the drugsâ first two weeks on the market.
Article â
Lansley Joins Roche in Latest Example of âRevolving Doorâ
The BMJ reports that renewed concerns about the ârevolving doorâ between government and industry have been sparked by the health minister of Englandâs decision to join to drug company Roche.
Treatment Guidelines Downplay Antidepressant Dependence
A review of treatment guidelines published in Psychotherapy and Psychosomatics found that guidelines âshy away from stating clearly that SSRIs/SNRIs, like BDZs, are often (though...
The ADHD Drug Abuse Crisis on College Campuses
The abuse of ADHD drugs on college campuses has reached epidemic proportions, according to the authors of a recent review in the journal of Ethical Human Psychology and Psychiatry. ADHD drugs, like Ritalin and Adderall, have become so commonplace on college campuses that students abusing these drugs for studying, weight loss and partying have underestimated their risks. As a result, we have seen exponential increases in emergency room visits, overdoses, and suicides by students taking these drugs.
âSilentâ Forms of Child Abuse Strongly Tied to Depression
Psychological abuse and childhood neglect are strongly associated with depression in adulthood, according to a meta-analysis of childhood trauma and depression published in this monthâs issue of the Journal of Affective Disorders. âThe findings clearly highlight the potential impact of the more âsilentâ types of childhood maltreatment (other than physical and sexual abuse) on the development of depression,â the researchers conclude.
âDoctors Say Exercise Can Relieve Depression Symptomsâ
âDoctors say one of the best anti-depressants isn't even a drug, it's exercise,â CNN reports. âExperts say many cases of depression can be treated effectively with, for example, a pair of running shoes.â
Rise in Psychiatric Prescriptions With NOS Diagnosis
A ânot otherwise specifiedâ (NOS) diagnosis is often used when an individual may have some symptoms related to a psychiatric diagnosis but does not meet enough criteria to warrant a particular diagnosis. A new study, published online ahead of print in Psychiatric Services, reveals that the proportion of mental health visits resulting in such NOS diagnoses rose to nearly fifty percent, and that these diagnoses do not result in more conservative psychiatric drug prescriptions.
Brain Imaging Reveals Psychiatric Disorders are Not Neurological Disorders
Some researchers have been arguing to reclassify all psychiatric disorders as diseases of the brain and nervous system, similar to epilepsy or Parkinson's disease. Neuroimaging research, however, reveals that psychiatric disorders appear to be distinct from neurological disorders, according to a new study published in this monthâs issue of the British Journal of Psychiatry.
Identifying Psychiatric Drugs Leading to Emergency Room Visits
More than ten-percent of adults in the United States are currently prescribed at least one psychiatric medication but there is currently a lack of research on the prevalence of adverse drug events (ADEs) associated with these prescriptions outside of clinical trials.
âNature and Nurture: Human Brains Evolved to be More Responsive to Environmental Influencesâ
"We found that the anatomy of the chimpanzee brain is more strongly controlled by genes than that of human brains, suggesting that the human brain is extensively shaped by its environment no matter its genetics," said Aida GĂłmez-Robles, postdoctoral scientist at the GW Center for the Advanced Study of Human Paleobiology and lead author on the paper. "So while genetics determined human and chimpanzee brain size, it isn't as much of a factor for human cerebral organization as it is for chimpanzees."
âDoctors Call for Drug Advertising Ban in Position Reversalâ
On Tuesday, the American Medical Association (AMA) declared its opposition to direct-to-consumer advertising for prescription drugs. The US is one of the few countries that still allows drug companies to advertise prescription drugs in television commercials and magazines.